Gene Logic Inc. Uses Staccato to Generate Gene Expression Data

<%=company1%> is pleased to announce that Gene Logic Inc. has chosen to use a Staccato Applications-Focused Workstation. Staccato's innovative liquid handling, stacking and control software technologies provide a uniform architecture using reliable and economical building blocks. Gene Logic will use the technology for multi-gene screening as part of its effort to generate the highest quality gene expression data.

"We are involved in a research collaboration focused on screening compounds against a large number of genes. We require a system that could be easily reconfigured as gene targets change or gene expression assays evolve," commented Eric Eastman, Senior Vice President and Chief Technology Officer for Gene Logic. "Staccato will help us more efficiently measure the expression level of genes after the cells have been treated with compounds from a library. We are very excited to utilize this instrumentation in our multi-gene screening efforts for our custom discovery collaboration partner."

"Our goal with Staccato is to provide scientists with a cost-efficient package that integrates the instruments most often used to accomplish specific goals in laboratory environments," stated Zymark Corporation President and CEO Kevin Hrusovsky. "By carefully consolidating our offerings around what we know laboratories and scientists truly need, we are able to play a part in the challenge to get new drugs to market as quickly and cost efficiently as possible. With the Staccato technologies, Gene Logic is poised to accelerate their drug screening initiatives."